It was shown that activation of TLR4 decreased the action potential duration of cardiomyocytes via the IRF-3 pathway, a MyD88-independent pathway that leads to cardiac arrhythmias [107]. This evidence concerns the gene TLR4 and cardiac rhythm disease.